Corbus Pharmaceuticals logo

Corbus Pharmaceuticals share price today

(CRBP)

Corbus Pharmaceuticals share price is $11.93 & ₹1,032.72 as on 22 Jan 2025, 2.30 'hrs' IST

$11.93

0.01

(0.08%)

Market is closed - opens 8 PM, 22 Jan 2025

View live Corbus Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Corbus Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Corbus Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Corbus Pharmaceuticals share price movements

  • Today's Low: $11.62
    Today's High: $12.39

    Day's Volatility :6.2%

  • 52 Weeks Low: $6.63
    52 Weeks High: $61.90

    52 Weeks Volatility :89.29%

Corbus Pharmaceuticals Returns

PeriodCorbus Pharmaceuticals Holdings, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-28.15%
-7.4%
0.0%
6 Months
-78.11%
-5.2%
0.0%
1 Year
63.29%
0.5%
0.0%
3 Years
-15.48%
8.3%
-11.0%

Corbus Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$11.92
Open
$12.0
Today's High
$12.3881
Today's Low
$11.62
Market Capitalization
$145.2M
Today's Volume
$184.3K
52 Week High
$61.9
52 Week Low
$6.63
Revenue TTM
$0.0
EBITDA
$-45.6M
Earnings Per Share (EPS)
$-4.71
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-51.32%

How to invest in Corbus Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Corbus Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Corbus Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Corbus Pharmaceuticals or CRBP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Corbus Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Corbus Pharmaceuticals shares which would translate to 0.073 fractional shares of Corbus Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Corbus Pharmaceuticals, in just a few clicks!

Returns in Corbus Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Corbus Pharmaceuticals investment value today

Current value as on today

₹1,67,554

Returns

₹67,554

(+67.55%)

Returns from Corbus Pharmaceuticals Stock

₹63,425 (+63.42%)

Dollar Returns

₹4,130 (+4.13%)

Indian investors sentiment towards Corbus Pharmaceuticals

13%

Period: Oct 23, 2024 to Jan 21, 2025. Change in 30 Days versus previous period

Search volume for Corbus Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Jan 22, 2025. 13% more investors are searching Corbus Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Corbus Pharmaceuticals

  • Cormorant Asset Management, LLC

    19.50%

  • Octagon Capital Advisors LP

    9.15%

  • Orbimed Advisors, LLC

    7.49%

  • BlackRock Inc

    6.59%

  • Vanguard Group Inc

    5.30%

  • TANG CAPITAL MANAGEMENT LLC

    4.93%

Analyst Recommendation on Corbus Pharmaceuticals

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Corbus Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Corbus Pharmaceuticals

What analysts predicted

Upside of 375.92%

Target:

$56.78

Current:

$11.93

Insights on Corbus Pharmaceuticals

  • Price Movement

    In the last 6 months, CRBP stock has moved down by -79.4%
  • CRBP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 80.5% return, outperforming this stock by 95.4%

Corbus Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Corbus Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Corbus Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Corbus Pharmaceuticals Holdings, Inc. logo
-9.42%
-78.11%
63.29%
-15.48%
-94.08%
Biontech Se logo
-1.39%
34.63%
11.61%
-25.86%
219.89%
Regeneron Pharmaceuticals, Inc. logo
-4.69%
-35.75%
-28.6%
9.67%
97.4%
Vertex Pharmaceuticals Incorporated logo
4.13%
-14.02%
-4.03%
83.73%
84.23%
Alnylam Pharmaceuticals, Inc. logo
1.66%
4.14%
29.82%
80.38%
105.23%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Corbus Pharmaceuticals Holdings, Inc. logo
NA
NA
0.0
-4.38
-0.51
-0.29
NA
12.36
Biontech Se logo
160.8
NA
0.04
-3.34
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.86
16.86
1.05
44.99
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.1
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Corbus Pharmaceuticals Holdings, Inc. logo
Buy
$145.2M
-94.08%
NA
0.0%
Biontech Se logo
Buy
$26.8B
219.89%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
97.4%
16.86
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$108.7B
84.23%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.8B
105.23%
NA
-15.86%

About Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Organization
Corbus Pharmaceuticals
Employees
19
CEO
Dr. Yuval Cohen Ph.D.
Industry
Health Technology

Management People of Corbus Pharmaceuticals

NameTitle
Dr. Yuval Cohen Ph.D.
CEO & Director
Ms. Lindsey Smith
Head of Corporate Communications & Patient Advocacy
Ms. Christina Bertsch
Vice President of Human Resources
Dr. Dominic Smethurst M.A., M.D.
Chief Medical Officer

Important FAQs about investing in Corbus Pharmaceuticals from India :

What is Corbus Pharmaceuticals share price today?

Corbus Pharmaceuticals share price today stands at $11.93, Open: $12.00 ; Previous Close: $11.92 ; High: $12.39 ; Low: $11.62 ; 52 Week High: $61.90 ; 52 Week Low: $6.63. The stock opens at $12.00, after a previous close of $11.92. The stock reached a daily high of $12.39 and a low of $11.62, with a 52-week high of $61.90 and a 52-week low of $6.63.

Can Indians buy Corbus Pharmaceuticals shares?

Yes, Indians can invest in the Corbus Pharmaceuticals (CRBP) from India.

With INDmoney, you can buy Corbus Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Corbus Pharmaceuticals at zero transaction cost.

How can I buy Corbus Pharmaceuticals shares from India?

It is very easy to buy Corbus Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Corbus Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Corbus Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Corbus Pharmaceuticals stocks?

To start investing in Corbus Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Corbus Pharmaceuticals

Today’s highest price of Corbus Pharmaceuticals (CRBP) is $12.39.

Today’s lowest price of Corbus Pharmaceuticals (CRBP) is $11.62.

What is today's market capitalisation of Corbus Pharmaceuticals

Today's market capitalisation of Corbus Pharmaceuticals CRBP is 145.2M

What is the 52 Week High and Low Range of Corbus Pharmaceuticals

  • 52 Week High

    $61.90

  • 52 Week Low

    $6.63

What are the historical returns of Corbus Pharmaceuticals?

  • 1 Month Returns

    -9.42%

  • 3 Months Returns

    -78.11%

  • 1 Year Returns

    63.29%

  • 5 Years Returns

    -94.08%

Who is the Chief Executive Officer (CEO) of Corbus Pharmaceuticals

Dr. Yuval Cohen Ph.D. is the current Chief Executive Officer (CEO) of Corbus Pharmaceuticals.